Log in

NASDAQ:ATECAlphatec Stock Price, Forecast & News

$4.50
+0.05 (+1.12 %)
(As of 07/13/2020 04:00 PM ET)
Add
Compare
Today's Range
$4.39
Now: $4.50
$4.61
50-Day Range
$4.40
MA: $4.82
$5.59
52-Week Range
$2.19
Now: $4.50
$7.93
Volume227,900 shs
Average Volume392,829 shs
Market Capitalization$288.23 million
P/E RatioN/A
Dividend YieldN/A
Beta1.94
Alphatec Holdings, Inc., a medical technology company, focuses on the design, development, and promotion of products for the surgical treatment of spine disorders. Its product portfolio and pipeline address the cervical, thoracolumbar, and intervertebral regions of the spine; and cover various spinal disorders and surgical procedures. The company offers MIS products consisting of Battalion Lateral Spacer System and Squadron Lateral Retractor, Illico Minimally Invasive Surgery System, and BridgePoint Spinous Process Fixation System; and fixation products, such as Arsenal Screw System and Zodiac Spinal Fixation Systems. It also provides cervical and cervico-thoracic products, including Trestle Luxe Anterior Cervical Plate System, and Solanas Posterior Cervico/Thoracic Fixation System and Avalon Occipital Plate; and interbody Systems, such as Battalion Universal Spacer System, Novel PEEK and Titanium Spinal Spacers, and Alphatec Solus Locking ALIF Spinal Spacer. In addition, the company offers biologics consisting of AlphaGraft Structural Allograft Spacers, AlphaGraft ProFuse Demineralized Bone Scaffold, Amnioshield Amniotic Tissue Barrier, Alphagraft Demineralized Bone Matrix, and Neocore Osteoconductive Matrix. It sells its products through a network of independent distributors and direct sales representatives in the United States. Alphatec Holdings, Inc. was founded in 1990 and is headquartered in Carlsbad, California.
Read More
Alphatec logo

Beat the Market (BTM) Rank

Analyst Opinion: 3.5Community Rank: 1.9Dividend Strength: 0.0Insider Behavior: 1.0Valuation: 0.6 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.41 out of 5 stars


Industry, Sector and Symbol

Industry Surgical & medical instruments
Sub-IndustryHealth Care Equipment
SectorMedical
Current SymbolNASDAQ:ATEC
CUSIP02081G10
Phone760-431-9286

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$113.43 million
Book Value$0.71 per share

Profitability

Net Income$-57,000,000.00

Miscellaneous

Employees195
Market Cap$288.23 million
Next Earnings Date7/22/2020 (Estimated)
OptionableNot Optionable

Receive ATEC News and Ratings via Email

Sign-up to receive the latest news and ratings for ATEC and its competitors with MarketBeat's FREE daily newsletter.

Alphatec (NASDAQ:ATEC) Frequently Asked Questions

How has Alphatec's stock been impacted by COVID-19 (Coronavirus)?

Alphatec's stock was trading at $4.41 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization (WHO). Since then, ATEC stock has increased by 2.0% and is now trading at $4.50. View which stocks have been most impacted by Coronavirus.

Do Wall Street analysts recommend investors buy shares of Alphatec?

5 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Alphatec in the last year. There are currently 5 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View analyst ratings for Alphatec.

When is Alphatec's next earnings date?

Alphatec is scheduled to release its next quarterly earnings announcement on Wednesday, July 22nd 2020. View our earnings forecast for Alphatec.

How were Alphatec's earnings last quarter?

Alphatec Holdings Inc (NASDAQ:ATEC) announced its earnings results on Monday, May, 11th. The medical technology company reported ($0.33) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.20) by $0.13. The medical technology company had revenue of $30.12 million for the quarter, compared to analyst estimates of $29.82 million. Alphatec had a negative return on equity of 167.29% and a negative net margin of 54.42%. View Alphatec's earnings history.

What price target have analysts set for ATEC?

5 brokerages have issued 12 month price targets for Alphatec's shares. Their forecasts range from $7.00 to $15.00. On average, they expect Alphatec's stock price to reach $9.50 in the next year. This suggests a possible upside of 111.1% from the stock's current price. View analysts' price targets for Alphatec.

Has Alphatec been receiving favorable news coverage?

News headlines about ATEC stock have been trending somewhat positive recently, according to InfoTrie. InfoTrie identifies negative and positive media coverage by analyzing more than six thousand blog and news sources in real time. The firm ranks coverage of public companies on a scale of -5 to 5, with scores closest to five being the most favorable. Alphatec earned a news impact score of 1.8 on InfoTrie's scale. They also assigned news stories about the medical technology company a news buzz of 0.0 out of 10, indicating that recent media coverage is extremely unlikely to have an effect on the stock's share price in the near future. View the latest news about Alphatec.

Who are some of Alphatec's key competitors?

What other stocks do shareholders of Alphatec own?

Who are Alphatec's key executives?

Alphatec's management team includes the following people:
  • Mr. Patrick S. Miles, Exec. Chairman & CEO (Age 53)
  • Mr. Craig E. Hunsaker, Exec. VP of People & Culture, Corp. Sec. and Gen. Counsel (Age 55)
  • Mr. Terry M. Rich, Consultant (Age 51)
  • Mr. Jeffrey P. Rydin, Director (Age 52)
  • Mr. Jeffrey G. Black, Exec. VP & CFO (Age 50)

What is Alphatec's stock symbol?

Alphatec trades on the NASDAQ under the ticker symbol "ATEC."

How do I buy shares of Alphatec?

Shares of ATEC can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Alphatec's stock price today?

One share of ATEC stock can currently be purchased for approximately $4.50.

How big of a company is Alphatec?

Alphatec has a market capitalization of $288.23 million and generates $113.43 million in revenue each year. The medical technology company earns $-57,000,000.00 in net income (profit) each year or ($1.09) on an earnings per share basis. Alphatec employs 195 workers across the globe.

What is Alphatec's official website?

The official website for Alphatec is www.atecspine.com.

How can I contact Alphatec?

Alphatec's mailing address is 5818 EL CAMINO REAL, CARLSBAD CA, 92008. The medical technology company can be reached via phone at 760-431-9286 or via email at [email protected]

This page was last updated on 7/14/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.